Journal articleEur J Cancer2009
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
- Journal
- Eur J Cancer
- Published
- 1 January 2009
- Citations
- 23,345
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 14
- BackgroundOnvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer NCT06736717↗
- BackgroundNamodenoson Treatment of Advanced Pancreatic Cancer NCT06387342↗
- BackgroundCombined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma NCT05955157↗
- BackgroundThe First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients NCT05168527↗
- BackgroundExploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With … NCT04787991↗
- Background1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma NCT04098081↗
- BackgroundPerioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery NCT04025840↗
- BackgroundChromogranin A as Blood Marker in Cancer Patients NCT03817866↗
- BackgroundA Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX NCT03450018↗
- BackgroundDiagnostic Accuracy of Preoperative Diagnostic Procedure in the Assessment of Lymph Node Metastases by NF-PanNENs NCT03918759↗
- BackgroundTrial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma NCT03077685↗
- BackgroundProspectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis NCT02869802↗
- BackgroundStudy of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies NCT02433626↗
- BackgroundTolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation NCT02159248↗